글로벌 요분석 테스트 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

요분석 검사 시장 분석

소변의 농도, 외관, 함량은 모두 요분석 검사에서 검사합니다. 비정상적인 요분석 결과는 질병을 나타낼 수 있습니다  . 소변 검사 결과가 양성이면 신장이 제대로 기능하지 않거나 혈액을 제대로 걸러내지 못한다는 것을 나타낼 수 있습니다. 잠재적으로 심혈관 질환의 징후일 수 있습니다. 요분석은 여성이 임신했는지 또는 배란 중인지 여부를 확인하기 위해 수행할 수도 있습니다.

요분석 검사 시장 규모

글로벌 요분석 검사 시장 규모는 2023년에 41억 6천만 달러로 평가되었으며, 2031년까지 82억 9천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률은 9.00%입니다.

보고 범위 및 시장 세분화       

요분석 테스트 시장 정의

Urinalysis tests are a group of tests that use urine as a sample to detect symptoms of a variety of disorders. It's one of the most important tests for detecting any indicators of liver illness, diabetes, or kidney disease. Chemical evaluation, microscopic examination, and gross examination are the three types of urinalysis tests.

Urinalysis Test Market Dynamics

Drivers

• Rise in the geriatric population

The prevalence of age-related disorders such as diabetes, liver, and renal disease is predicted to rise dramatically as the senior population grows, further accelerating the growth of the market.

• Growing prevalence of urinary tract infection

One of the primary elements propelling the market forward is the rising prevalence of urinary tract infections (UTIs) in developing economies. If left untreated, urinary tract infections (UTIs) can spread to the kidneys and cause birth difficulties in pregnant women, contributing to market growth.

• Increase in the incidence of chronic kidney diseases globally

Furthermore, the 13.3 million people worldwide who suffer from acute kidney injury (AKI) each year are at risk of developing CKD or renal failure in the coming years which is further anticipated to propel the growth of the market.

Opportunities

In addition, the technological development in urine analyzers is further estimated to provide potential opportunities for the growth of the urinalysis test market in the coming years.

Restraints/Challenges

On the other hand, the accessibility of refurbished urine analyzers is further projected to impede the growth of the urinalysis test market in the targeted period. However, the shift in the regulatory landscape might further challenge the growth of the urinalysis test market in the near future.

This urinalysis test market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinalysis test market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Urinalysis Test Market

The pandemic of COVID-19 has had a huge impact on the urinalysis test market. COVID-19 patients are more likely to have acute kidney damage (AKI), leading to major health problems, including death. As a result, patients are advised to see a nephrologist on a frequent basis to avoid any further health concerns. However, in the post-COVID scenario, Companies have made strategic decisions to implement COVID-19 rapid tests, maintain revenues, and mitigate COVID-19's impact on their operating capabilities.

Urinalysis Test Market Scope

The urinalysis test market is segmented on the basis of product, test type, application, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Consumables
• Instruments

On the basis of product type, the urinalysis test market is segmented into consumables and instruments. Consumables are further segmented into pregnancy and fertility kits, dipsticks, disposables, and reagents. Instruments are further segmented into automated urine analyzers, semi-automated urine analyzers, and point-of-care urine analyzers. Biochemical urinalysis are further segmented into laboratory tests and point-of-care tests.

Test Type

• Pregnancy and Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

On the basis of test type, the urinalysis test market is segmented into pregnancy and fertility tests, biochemical urinalysis and sediment urinalysis.

Application

• Disease Screening
• Pregnancy
• Fertility

On the basis of application, the urinalysis test market is segmented into disease screening, and pregnancy and fertility. Disease screening is further segmented into urinary tract infections, kidney diseases, diabetes, liver diseases and other disease screening applications.

End user

• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care Settings
• Research Laboratories and Institutes

On the basis of end user, the urinalysis test market is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes.

Urinalysis Test Market Regional Analysis          

The urinalysis test market is analysed and market size insights and trends are provided by country, product, test type, application, and end user as referenced above.

The countries covered in the urinalysis test market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the urinalysis test market due to the increase in the cases of chronic diseases related to liver and kidney, diabetes. Furthermore, the development in technology will further boost the growth of the urinalysis test market in the region during the forecast period.

Asia-Pacific is projected to observe a significant amount of growth in the urinalysis test market due to the rise in technological developments by local companies.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Urinalysis Test Market Share

The urinalysis test market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urinalysis test market.

Urinalysis Test Market Leaders Operating in the Market Are:

• Abbott (US)
• Medtronic (US)
• Siemens (Germany)
• General Electric Company (US)
• BD (US)
• Thermo Fisher Scientific (US)
• 77 Elektronika Kft (Hungary)
• Bio-Rad Laboratories Inc. (US)
• Sysmex Corporation (Japan)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Cardinal Health (US)
• Beckman Coulter Inc. (US)
• ACON Laboratories Inc. (US)
• ARKRAY Inc. (Japan)
• Penn Medicine Lancaster General Health. (US)
• BioMaxima SA (Poland)
• Quidel Corporation (US)
• Metropolis India (India)
• Dr Lal PathLabs (India)
• Trinity Biotech (Ireland)

Latest Developments in Urinalysis Test Market

• 2020년 8월, Siemens Healthineers는 Sysmex America, Inc.에 북미 지역 병원 및 참고 실험실에서 사용할 Siemens Healthineers CLINITEK Novus 자동 소변 분석기를 배포하고 서비스할 수 있는 독점권을 부여했습니다.

SKU-13269